Skip to main content
. 2021 Nov 22;12:780937. doi: 10.3389/fphar.2021.780937

FIGURE 3.

FIGURE 3

Predicted mean plasma concentration–time curves of apatinib with or without co-administration of CYP2D6 inhibitors, fluvoxamine (A), quinidine (B), and paroxetine (C).